HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.

AbstractPurpose:
Matrix metalloproteinase-14 (MMP-14) is a transmembrane MMP that plays a critical role in promoting angiogenesis. We investigated the expression levels of MMP-14 and correlated the levels with clinical disease activity and with the levels of the angiogenic factors vascular endothelial growth factor (VEGF) and MMP-9 in proliferative diabetic retinopathy (PDR). To reinforce the findings at the functional level, we examined the expression of MMP-14 in the retinas of diabetic rats.
Methods:
Vitreous samples from 34 patients with PDR and 18 nondiabetic patients and epiretinal membranes from 13 patients with PDR and the retinas of rats were studied with enzyme-linked immunosorbent assay, immunohistochemistry, western blotting, and real-time reverse transcription PCR (RT-PCR).
Results:
The MMP-14, VEGF, and MMP-9 levels were statistically significantly higher in the vitreous samples from patients with PDR than in the samples from the nondiabetic controls (p<0.001 for all comparisons). The MMP-14 levels in patients with PDR with active neovascularization were statistically significantly higher than those in patients with inactive PDR (p<0.001). There were statistically significant positive correlations between levels of MMP-14 and levels of VEGF (r = 0.3; p = 0.032) and MMP-9 (r = 0.54; p<0.001). In the epiretinal membranes, MMP-14 was expressed in vascular endothelial cells, leukocytes, and myofibroblasts. Statistically significant positive correlations were detected between the numbers of blood vessels expressing CD31 and the numbers of blood vessels (r = 0.74; p = 0.004) and stromal cells (r = 0.72; p = 0.005) expressing MMP-14. Statistically significant increases of MMP-14 mRNA and protein were detected in rat retinas after induction of diabetes.
Conclusions:
These results suggest that MMP-14 is involved in PDR angiogenesis.
AuthorsAhmed M Abu El-Asrar, Ghulam Mohammad, Eef Allegaert, Ajmal Ahmad, Mohammad Mairaj Siddiquei, Kaiser Alam, Priscilla W Gikandi, Gert De Hertogh, Ghislain Opdenakker
JournalMolecular vision (Mol Vis) Vol. 24 Pg. 394-406 ( 2018) ISSN: 1090-0535 [Electronic] United States
PMID29853773 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
  • MMP14 protein, human
  • Matrix Metalloproteinase 14
Topics
  • Adult
  • Aged
  • Animals
  • Biomarkers (metabolism)
  • Blood Vessels (metabolism, pathology)
  • Case-Control Studies
  • Diabetes Mellitus, Experimental (genetics, metabolism, pathology)
  • Diabetic Retinopathy (genetics, metabolism, pathology)
  • Endothelial Cells (metabolism, pathology)
  • Female
  • Gene Expression Regulation
  • Humans
  • Leukocytes (metabolism, pathology)
  • Male
  • Matrix Metalloproteinase 14 (genetics, metabolism)
  • Matrix Metalloproteinase 9 (genetics, metabolism)
  • Middle Aged
  • Myofibroblasts (metabolism, pathology)
  • Neovascularization, Pathologic (genetics, metabolism, pathology)
  • Rats
  • Retina (metabolism, pathology)
  • Retinal Neovascularization (genetics, metabolism, pathology)
  • Signal Transduction
  • Vascular Endothelial Growth Factor A (genetics, metabolism)
  • Vitreous Body (blood supply, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: